Wegovy: Specifically approved for chronic weight management in adults with a BMI of 30 kg/m, or 27 kg/m with weight-related medical diseases/conditions
21, 2025, the FDA announced that the semaglutide shortage was over, giving compounding pharmacies a deadline to stop distributing compounded semaglutide thats essentially identical to FDA-approved versions
Specifically, it stimulates anorexigenic neurons (the ones that create feelings of fullness) while inhibiting orexigenic neurons (the ones that drive hunger)
How Semaglutide Might Raise Your Heart Rate Semaglutide is a glucagon-like peptide-1 receptor agonist that acts on multiple tissues
Understanding these important points can help individuals navigate their weight loss journey with greater confidence
Understanding how semaglutide makes you feel underscores this point: the effects are metabolic and appetite-related, not psychoactive